Monday, November 9, 2026

GBP/USD Pre-data Anxiety: (GBPUSD) Is 1% Down In The Last 5 Sessions

Via News Just in

July 24, 2023

GBP/USD Pre-data Anxiety: (GBPUSD) Is 1% Down In The Last 5 Sessions
(VIANEWS) - GBP/USD remains sidelined while licking its wounds around 1.2850 after the heavy weekly fall during early Monday morning in Asia. In doing so, the Cable pair seesaws between the 100 and 200 Exponential Moving Average (EMA) as the oscillators appear poking bears ahead of the key preliminary readings of the UK and US PMIs for July. As reported by FXStreet, also read:GBP/USD Weekly Forecast: Down but not out, awaiting the Fed With this, GBP/USD remains sidelined unless trading between the aforementioned EMA envelope, currently between 1.2890 and 1.2790. GBP/USD (GBPUSD) has been up by 1.74% for the last 5 sessions. At 04:08 EST on Monday, 24 July, GBP/USD (GBPUSD) is $1.28.

Gbp/usd price analysis: cable portrays pre-data anxiety within key EMA envelope around 1.2850

With this, GBP/USD remains sidelined unless trading between the aforementioned EMA envelope, currently between 1.2890 and 1.2790., Meanwhile, a downside break of the 200-EMA support of around 1.2790 isn't a clear call for the GBP/USD sellers as an upward-sloping support line from late May, near 1.2770 at the latest, could challenge the bears.

Pound sterling price news and forecast: gbp/usd recovers early lost ground to the 1.2860 area

The GBP/USD pair attracts some follow-through buying and bounces off the 1.2815 mark on Monday. , With this, GBP/USD remains sidelined unless trading between the aforementioned EMA envelope, currently between 1.2890 and 1.2790. GBP/USD's yearly highs and lows, it's 23.788% up from its 52-week low and 2.237% down from its 52-week high.

Volatility

GBP/USD's last week, last month's, and last quarter's current intraday variation average was a negative 0.36%, a positive 0.04%, and a positive 0.37%, respectively. GBP/USD's highest amplitude of average volatility was 0.36% (last week), 0.39% (last month), and 0.37% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/USD's Forex is considered to be overbought (>=80).

Previous days news about GBP/USD (GBPUSD)

  • Pound sterling price news and forecast: gbp/usd drops amid strong US dollar. According to FXStreet on Saturday, 22 July, "The GBP/USD trades at 1.2851, losing 0012%, after hitting a daily high of 1.2904. "
  • Gbp/usd: weekly forecast 23rd July - 29th July - 23 July 2023. According to DailyForex on Sunday, 23 July, "The Fed's FOMC Statement will produce price velocity in the GBP/USD as reactions mount. ", "The GBP/USD did climb above 1.31000 momentarily on Monday and fought to its high for the week on Tuesday near the 1.31270 vicinity, before the wheels fell off for bullish traders and values started to see strong selling ignite and continue the remainder of the week."
More news about GBP/USD (GBPUSD).
Via News Just in

Breaking news and real-time updates on financial markets, business developments, and economic events from Via News.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com